Πέμπτη 3 Αυγούστου 2017

Potential Pitfall of Pluripotent Stem Cells

NEJM_PC_global_header.gif

Pluripotent stem cells are entering early phase 1 and 2 clinical trials for a range of applications, including the treatment of macular degeneration and other eye diseases, spinal cord injury, heart disease, type 1 diabetes, and Parkinson's disease. By necessity, both pluripotent embryonic stem…

http://ift.tt/2woq4JG

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου